Summary & Overview
CPT 65778: Amniotic Membrane Placement on Ocular Surface
CPT code 65778 covers placement of an amniotic membrane on the ocular surface, a therapeutic ophthalmic procedure used to promote corneal and conjunctival healing. Nationally, this procedure matters because it addresses refractory epithelial defects, surface inflammation, and other conditions where biologic membrane support can reduce morbidity and improve visual outcomes. Use of amniotic membrane techniques has increased as clinicians seek alternatives to more invasive procedures and as product availability and coverage policies evolve.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find an overview of how CPT code 65778 is defined clinically, typical sites of service, common billing modifiers, and where national payers tend to focus their medical necessity and coverage policies. The publication also summarizes benchmark considerations such as coding nuances, claim bundling risks, and documentation elements that commonly affect payment adjudication.
This summary provides clinicians, billing staff, and policy analysts with concise context on the clinical purpose of CPT code 65778, the payer landscape nationally, and the types of benchmarks and policy details to review when preparing or auditing claims for amniotic membrane placement on the ocular surface.
Billing Code Overview
CPT code 65778 describes placement of an amniotic membrane on the ocular surface, applied in a manner similar to placement of a contact lens. The procedure is an ocular surface repair/therapy intended to support healing, protect the cornea or conjunctiva, and provide a biologic scaffold for epithelial regeneration.
Service type: Ophthalmic surgical/therapeutic procedure
Typical site of service: Ophthalmology clinic, ambulatory surgical center, or hospital outpatient department
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with ocular surface disease such as persistent epithelial defects, corneal ulcers, chemical injury, or severe dry eye unresponsive to conservative therapy. The patient presents to an ophthalmology clinic or ambulatory surgery center for placement of an amniotic membrane as a biologic bandage. After history, visual acuity, slit-lamp exam, and fluorescein staining confirm an epithelial defect or surface inflammation, the provider selects either a cryopreserved or dehydrated amniotic membrane. The procedure is performed under topical anesthesia in the clinic procedure room or minor procedure suite. The membrane is fashioned and placed onto the ocular surface, secured as a scleral contact-lens-like device or with tissue adhesive/sutures per technique. Post-procedure care includes topical antibiotics, lubricants, and scheduled follow-up visits for membrane assessment and removal if indicated. Typical workflow steps: pre-procedure informed consent and documentation of indication and alternatives; topical anesthesia and sterile field preparation; placement/securement of the amniotic membrane; immediate post-procedure exam and patient instructions; documented follow-up plan for membrane maintenance or removal.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable E/M service by the same physician on the same day | Use when a distinct E/M visit is provided on the same day as 65778 and documentation supports separate evaluation and management. |